E
Orchestra BioMed Holdings, Inc. OBIO
$2.60 $0.051.96% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -69.70M -66.32M -61.02M -57.69M -55.58M
Total Depreciation and Amortization 324.00K 317.00K 308.00K 296.00K 291.00K
Total Amortization of Deferred Charges 123.00K 77.00K 31.00K 3.00K 39.00K
Total Other Non-Cash Items 12.51M 11.78M 10.89M 8.91M 8.94M
Change in Net Operating Assets -2.63M 79.00K -765.00K 482.00K 1.73M
Cash from Operations -59.38M -54.06M -50.56M -47.99M -44.58M
Capital Expenditure -320.00K -393.00K -289.00K -180.00K -131.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -602.00K -602.00K -602.00K -- --
Divestitures -- -- -- -- --
Other Investing Activities 27.08M 21.22M 13.98M 50.17M 62.51M
Cash from Investing 26.16M 20.23M 13.09M 49.99M 62.38M
Total Debt Issued 15.00M 15.00M 15.00M -- --
Total Debt Repaid -- -- -- -10.85M -10.85M
Issuance of Common Stock 15.18M 15.35M 15.28M 15.38M 346.00K
Repurchase of Common Stock -1.37M -937.00K -550.00K -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -554.00K -554.00K -554.00K 0.00 0.00
Cash from Financing 28.26M 28.86M 29.17M 4.53M -10.50M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -4.96M -4.98M -8.30M 6.53M 7.30M